利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

7 条记录 (耗时 0.017 秒)

    AN A22K, DESB27, B29R, DES B30, AT EPSILON POSITION OF LYSINE 22 ACYLATED HUMAN INSULIN ANALOGUE.
    4.
    发明公开
    AN A22K, DESB27, B29R, DES B30, AT EPSILON POSITION OF LYSINE 22 ACYLATED HUMAN INSULIN ANALOGUE. 审中-公开
    A22K，DESB27，B29R，DES B30 AN DER EPSILON-POSITION VON LYSIN-22-ACYLITEM MENSCHLICHEM INSULIN-ANALOGON

    公开(公告)号：EP3110840A2

    公开(公告)日：2017-01-04

    申请号：EP15707102.8

    申请日：2015-02-26

    申请人： Novo Nordisk A/S

    发明人： MADSEN, Peter ,  HOSTRUP, Susanne ,  MÜNZEL, Martin ,  KJELDSEN, Thomas Børglum ,  HJØRRINGGAARD, Claudia Ulrich ,  FLEDELIUS, Christian

    IPC分类号： C07K14/62

    摘要： The present invention is in the therapeutic fields of drugs for medical conditions relating to diabetes. More specifically the invention relates to novel acylated derivatives of human insulin analogues. The invention also provides pharmaceutical compositions comprising such insulin derivatives, and relates to the use of such derivatives for the treatment or prevention of medical conditions relating to diabetes.

    摘要翻译： 本发明涉及与糖尿病有关的医疗状况的药物的治疗领域。 更具体地，本发明涉及人类胰岛素类似物的新型酰化衍生物。 本发明还提供包含这种胰岛素衍生物的药物组合物，并且涉及这种衍生物用于治疗或预防与糖尿病相关的医学病症的用途。